BoxX-NoAF Trial: Preventing Stroke During Heart Surgery
Part of Heart & circulation clinical trials.
This trial tests a device to close a small pouch in the heart during planned bypass surgery, to help prevent future strokes. It is for people who have never had an irregular heartbeat and are at higher stroke risk due to age and other factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for heart surgery that uses a heart-lung machine and opens the sac around the heart.
- You are 65 or older and have a stroke risk score of 3 or higher.
- You have never had atrial fibrillation or atrial flutter.
- You have never had surgery that opened the sac around the heart before.
- You have not had any procedure to close, block, or remove the left atrial appendage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device to help doctors safely enter the left side of your heart during a procedure called ablation. If you are already scheduled for an ablation or a combined ablation and left atrial appendage closure, this study may be an option.
This trial tests the Zenith system, a device that seals off a heart area called the left atrial appendage to reduce stroke risk in people with atrial fibrillation (AF). You may be eligible if you have AF and a doctor recommends LAA closure, and you can return for follow-up scans and visits.
This study tests a procedure that seals off the left atrial appendage (a small heart pouch) to help prevent stroke in people with atrial fibrillation. You may be considered if your stroke risk is high and you are already on blood-thinner medicine.
This study looks at whether an added heart device approach around the time of planned open-heart surgery can help treat non-paroxysmal atrial fibrillation (AF), a long-lasting irregular heartbeat. It may help lower ongoing AF burden in people who also need non-emergency heart surgery.
This trial tests a new device used during open-heart surgery to treat atrial fibrillation (AFib) by delivering tiny, fast electrical pulses to the heart tissue. It is for people who are already having heart surgery and want to also treat their AFib at the same time.
This study tests a new device (AnchorMan®) that closes a small pouch in the heart to prevent strokes in people with atrial fibrillation. It is for patients who have a high stroke risk but cannot take blood thinners long-term.
Hear when a new Post Operative Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.